University of Virginia
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1819-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.virginia.edu
iSIPsmarter: An RCT to Evaluate the Efficacy of a Technology-based Behavioral Intervention to Reduce Sugary Beverages Among Rural Appalachian Adults
Not Applicable
Active, not recruiting
- Conditions
- Diet HabitSugar-Sweetened Beverages
- Interventions
- Behavioral: iSIPsmarterBehavioral: Patient Education (PE)
- First Posted Date
- 2021-09-01
- Last Posted Date
- 2023-05-12
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 245
- Registration Number
- NCT05030753
- Locations
- 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
Exercise Preconditioning in Ovarian Cancer
Not Applicable
Recruiting
- Conditions
- Ovarian Cancer
- Interventions
- Behavioral: High intensity interval exerciseBehavioral: Attention control
- First Posted Date
- 2021-08-31
- Last Posted Date
- 2024-08-07
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 27
- Registration Number
- NCT05029154
- Locations
- 🇺🇸
University of Virginia University Hospital, Charlottesville, Virginia, United States
Use of SPY Fluorescent Angiography to Reduce Ureteroenteric Stricture Rate Following Urinary Diversion
Not Applicable
- Conditions
- Stricture UreterUreteral Obstruction
- Interventions
- Device: SPY fluorescent angiography
- First Posted Date
- 2021-08-26
- Last Posted Date
- 2021-08-26
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 50
- Registration Number
- NCT05022199
- Locations
- 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
Fetal Cardiac Function Parameters and HbA1c As Screening for Gestational Diabetes Mellitus
Completed
- Conditions
- Gestational Diabetes
- First Posted Date
- 2021-08-25
- Last Posted Date
- 2025-01-16
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 114
- Registration Number
- NCT05019508
- Locations
- 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
Behavioral Activation for Treatment of Depression in Adolescents With Autism
Not Applicable
Completed
- Conditions
- DepressionAutism
- Interventions
- Behavioral: BA-A
- First Posted Date
- 2021-08-24
- Last Posted Date
- 2023-11-18
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 18
- Registration Number
- NCT05018169
- Locations
- 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
Optimizing Efficiency and Impact of Digital Health Interventions for Caregivers
Not Applicable
Completed
- Conditions
- Family CaregiversInsomniaSleep Initiation and Maintenance Disorders
- Interventions
- Behavioral: SHUTi (Sleep Healthy Using the Internet)
- First Posted Date
- 2021-08-03
- Last Posted Date
- 2024-10-23
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 102
- Registration Number
- NCT04986904
- Locations
- 🇺🇸
University of Pittsburgh, Pittsburgh, Pennsylvania, United States
🇺🇸University of Virginia, Charlottesville, Virginia, United States
Cardioprotection in AML
Phase 2
Recruiting
- Conditions
- AMLAcute Myeloid Leukemia
- Interventions
- Drug: Cardioprotection
- First Posted Date
- 2021-07-26
- Last Posted Date
- 2025-02-21
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 70
- Registration Number
- NCT04977180
- Locations
- 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
Liposomal Bupivacaine Versus Non-liposomal Bupivacaine for Total Shoulder Arthroplasty
- First Posted Date
- 2021-07-23
- Last Posted Date
- 2022-11-03
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 80
- Registration Number
- NCT04974385
- Locations
- 🇺🇸
University of Virginia Medical Center, Charlottesville, Virginia, United States
Exercise Preconditioning with Cancer Surgeries
Not Applicable
Terminated
- Conditions
- Hepatobiliary CancerGynecologic CancerColorectal Cancer
- Interventions
- Behavioral: Moderate continuous exerciseBehavioral: High intensity interval exercise
- First Posted Date
- 2021-06-11
- Last Posted Date
- 2024-10-16
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 10
- Registration Number
- NCT04923672
- Locations
- 🇺🇸
UVA Health System, Charlottesville, Virginia, United States
Safety and Efficacy of Dupilumab for Treatment of Hospitalized COVID-19 Patients
Phase 2
Completed
- Conditions
- COVID-19
- Interventions
- Drug: PlaceboBiological: Dupilumab
- First Posted Date
- 2021-06-10
- Last Posted Date
- 2023-11-03
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 40
- Registration Number
- NCT04920916
- Locations
- 🇺🇸
UVA Health, Charlottesville, Virginia, United States
© Copyright 2025. All Rights Reserved by MedPath